DPA-714

CAS No. 958233-07-3

DPA-714 ( —— )

Catalog No. M25016 CAS No. 958233-07-3

DPA-714 is a high affinity translocator protein (TSPO) ligand (Ki=7 nM).

Purity : >98% (HPLC)

COA Datasheet HNMR HPLC MSDS Handing Instructions
Size Price / USD Stock Quantity
5MG 205 In Stock
10MG 335 In Stock
25MG 566 In Stock
50MG 806 In Stock
100MG 1098 In Stock
200MG Get Quote In Stock
500MG Get Quote In Stock
1G Get Quote In Stock

Biological Information

  • Product Name
    DPA-714
  • Note
    Research use only, not for human use.
  • Brief Description
    DPA-714 is a high affinity translocator protein (TSPO) ligand (Ki=7 nM).
  • Description
    DPA-714 is a high affinity translocator protein (TSPO) ligand (Ki=7 nM). It is designed with a fluorine atom in its structure, allowing labelling with fluorine -18 and in vivo imaging using positron emission tomography. [18F]DPA-714 successfully assesses for the specific imaging of inflammation in various models of neuroinflammation and in a brain tumor model.
  • Synonyms
    ——
  • Pathway
    Others
  • Target
    Other Targets
  • Recptor
    TSPO
  • Research Area
    ——
  • Indication
    ——

Chemical Information

  • CAS Number
    958233-07-3
  • Formula Weight
    398.5
  • Molecular Formula
    C22H27FN4O2
  • Purity
    >98% (HPLC)
  • Solubility
    DMSO:41.67 mg/mL (104.57 mM; Need ultrasonic)
  • SMILES
    CCN(CC)C(Cc1c2nc(C)cc(C)n2nc1-c(cc1)ccc1OCCF)=O
  • Chemical Name
    ——

Shipping & Storage Information

  • Storage
    (-20℃)
  • Shipping
    With Ice Pack
  • Stability
    ≥ 2 years

Reference

1.James ML, et al. DPA-714, a new translocator protein-specific ligand: synthesis, radiofluorination, and pharmacologic characterization. J Nucl Med. 2008 May;49(5):814-22.
molnova catalog
related products
  • (RS)-MCPG

    (RS)-MCPG is a non-selective group I/II metabotropic glutamate receptor antagonist.

  • (-)-5-Isopropyl-2-Me...

    (-)-5-Isopropyl-2-Methyl-13-Cyclohexadiene is a natural compound.

  • Buquinolate

    Buquinolate is an anticoccidial agent used in poultry, and the medicated chickens can produce higher levels of egg production and gain weight. Buquinolate does not interfere with the formation of immunity against coccidia.